HRS Bibliography

Bibliography Search
Export 36 results:
Filters: Keyword is Alzheimer disease  [Clear All Filters]

2020

Kulminski AM, Shu L, Loika Y, et al. APOE region molecular signatures of Alzheimer's disease across races/ethnicities. Neurobiol Aging. 2020;87:141.e1-141.e8. doi:10.1016/j.neurobiolaging.2019.11.007.
http://www.ncbi.nlm.nih.gov/pubmed/31813627?dopt=Abstract
National Institute on Aging. Death certificates may not adequately report dementia as cause of death. News & Events.
Bailey L. Depression worsens over time for older caregivers of newly diagnosed dementia patients. Michigan News. https://news.umich.edu/depression-worsens-over-time-for-older-caregivers-of-newly-diagnosed-dementia-patients/. Published 2020.
Jutkowitz E, Gozalo P, Trivedi A, Mitchell LL, Gaugler JE. The Effect of Physical and Cognitive Impairments on Caregiving. Medical Care. 2020;58(7):601-609. doi:10.1097/mlr.0000000000001323 .
Oney M, White L, Coe NB. Out-of-Pocket Costs Attributable to Dementia: A Longitudinal Analysis. Innovation in Aging. 2020;4(Suppl 1):475-476. doi:10.1093/geroni/igaa057.1539.
Gayman D. Study: Racial disparities exist in cognitive health expectancies, despite educational attainment. Nebraska Today. https://news.unl.edu/newsrooms/today/article/study-racial-disparities-exist-in-cognitive-health-expectancies-despite/. Published 2020.

2019

Nazarian A, Arbeev KG, Yashkin AP, Kulminski AM. Genetic heterogeneity of Alzheimer's disease in subjects with and without hypertension. Geroscience. 2019;41(2):137-154. doi:10.1007/s11357-019-00071-5.
http://www.ncbi.nlm.nih.gov/pubmed/31055733?dopt=Abstract

2017

Gresenz CR. Effects of Alzheimer's Disease in the Prediagnosis Period on Financial Outcomes. Santa Monica, United States: The RAND Corporation; 2017.PDF icon 1046541.pdf (779.45 KB)
Stephan Y, Sutin AR, Luchetti M, Terracciano A. Feeling Older and the Development of Cognitive Impairment and Dementia. J Gerontol B Psychol Sci Soc Sci. 2017;72(6):966-973. doi:10.1093/geronb/gbw085.
http://www.ncbi.nlm.nih.gov/pubmed/27436103?dopt=Abstract

2016

Sheffrin M, Stijacic-Cenzer I, Steinman MA. Desire for predictive testing for Alzheimer's disease and impact on advance care planning: a cross-sectional study. Alzheimers Res Ther. 2016;8(1):55. doi:10.1186/s13195-016-0223-9.
http://www.ncbi.nlm.nih.gov/pubmed/27955707?dopt=Abstract
Walter S, Marden JR, Kubzansky LD, et al. Diabetic Phenotypes and Late-Life Dementia Risk: A Mechanism-specific Mendelian Randomization Study. Alzheimer Dis Assoc Disord. 2016;30(1):15-20. doi:10.1097/WAD.0000000000000128.
http://www.ncbi.nlm.nih.gov/pubmed/26650880?dopt=Abstract
Marden JR, Mayeda ER, Walter S, et al. Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up. Alzheimer Disease & Associated Disorders. 2016;30(3):195-202. doi:10.1097/WAD.0000000000000137.
Chaplin R, Davidson I. What are the experiences of people with dementia in employment?. Dementia (London). 2016;15(2):147-61. doi:10.1177/1471301213519252.
http://www.ncbi.nlm.nih.gov/pubmed/24419354?dopt=Abstract

2015

Ramanan VK, Nho K, Shen L, et al. FASTKD2 is associated with memory and hippocampal structure in older adults. Mol Psychiatry. 2015;20(10):1197-204. doi:10.1038/mp.2014.142.
http://www.ncbi.nlm.nih.gov/pubmed/25385369?dopt=Abstract
Mukherjee S, Walter S, Kauwe JSK, et al. Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses. Alzheimers Dement. 2015;11(12):1439-1451. doi:10.1016/j.jalz.2015.05.015.
http://www.ncbi.nlm.nih.gov/pubmed/26079416?dopt=Abstract

2014

Tschirhart EC, Du Q, Kelley AS. Factors influencing the use of intensive procedures at the end of life. J Am Geriatr Soc. 2014;62(11):2088-94. doi:10.1111/jgs.13104.
http://www.ncbi.nlm.nih.gov/pubmed/25376084?dopt=Abstract
J Roberts S, McLaughlin SJ, Connell CM. Public beliefs and knowledge about risk and protective factors for Alzheimer's disease. Alzheimers Dement. 2014;10(5 Suppl):S381-9. doi:10.1016/j.jalz.2013.07.001.
http://www.ncbi.nlm.nih.gov/pubmed/24630852?dopt=Abstract

2011

Plassman BL, Langa KM, McCammon RJ, et al. Incidence of dementia and cognitive impairment, not dementia in the United States. Annals of Neurology. 2011;70(3):418-426. doi:10.1002/ana.22362.
Brookmeyer R, Evans DA, Hebert L, et al. National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimer's & Dementia. 2011;7(1):61-73. doi:10.1016/j.jalz.2010.11.007.
Seshadri S, Beiser AS, Au R, et al. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2. Alzheimer's & Dementia. 2011;7(1):35-52. doi:10.1016/j.jalz.2010.12.002.
Weir DR, Wallace RB, Langa KM, et al. Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. Alzheimers Dement. 2011;7(1):94-109. doi:10.1016/j.jalz.2010.11.004.
http://www.ncbi.nlm.nih.gov/pubmed/21255747?dopt=Abstract
Wilson RS, Weir DR, Leurgans SE, et al. Sources of variability in estimates of the prevalence of Alzheimer's disease in the United States. Alzheimer's & Dementia. 2011;7(1):74-79. doi:10.1016/j.jalz.2010.11.006.
Rocca WA, Petersen RC, Knopman DS, et al. Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimer's & Dementia. 2011;7(1):80-93. doi:10.1016/j.jalz.2010.11.002.